Bretaris Genuair

aclidinium bromide · Covis Pharma Europe B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bretaris Genuair, covering 2025-02-25 to 2025-02-25. Get the full timeline:

Most recent: EMA Authorised: Bretaris Genuair (aclidinium bromide) — Covis Pharma Europe B.V.